Neuroblastoma in Zebrafish

This feed focuses on neuroblastoma in Zebrafish, as well as MYCN and ALK oncogenes which are highly expressed in neuroblastoma. Here is the latest research.

September 15, 2020
Open Access

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma

JCO Precision Oncology
Lieke M J van ZogchelGodelieve A M Tytgat
September 20, 2020

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

International Journal of Hematology
Naoki TakezakoKenshi Suzuki
September 13, 2020
Open Access

Identification of the Wallenda JNKKK as an Alk suppressor reveals increased competitiveness of Alk-expressing cells

Scientific Reports
Georg WolfstetterRuth H Palmer
September 19, 2020

A neuroskeletal atlas of the mouse limb

BioRxiv : the Preprint Server for Biology
M. R. LorenzErica L Scheller
September 15, 2020

Techniques for Open Surgical Resection of Brain Metastases

Neurosurgery Clinics of North America
Joshua L Wang, J Bradley Elder
September 15, 2020

Bisphenol A(BPA), BPS and BPB-induced oxidative stress and apoptosis mediated by mitochondria in human neuroblastoma cell lines

Ecotoxicology and Environmental Safety
Congcong WangRuifang Fan
September 15, 2020
Open Access

A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome with Recurrent Olfactory Neuroblastoma

Internal Medicine
Hironori AbeMasato Odawara
September 16, 2020

Promotion of Mitochondrial Protection by Emodin in Methylglyoxal-Treated Human Neuroblastoma SH-SY5Y Cells: Involvement of the AMPK/Nrf2/HO-1 Axis

Neurotoxicity Research
Marcos Roberto de OliveiraFlávia Bittencourt Brasil
September 19, 2020

Genetic variation associated with childhood and adult stature and risk of MYCN-amplified neuroblastoma

Cancer Medicine
Eleanor C SemmesKyle M Walsh
September 18, 2020

Human Skin Microcirculation

Comprehensive Physiology
Jean-Luc Cracowski, Matthieu Roustit
September 18, 2020
Open Access

Does sympathetic nervous system modulate tumor progression? A narrative review of the literature

Journal of Drug Assessment
Ioannis StavropoulosAnastasios Liverezas
September 19, 2020
Open Access

Soluble Cyanobacterial Carotenoprotein as a Robust Antioxidant Nanocarrier and Delivery Module

Eugene G MaksimovNikolai N Sluchanko
September 13, 2020
Open Access

Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Yuta YoshinoYogesh Dwivedi
September 20, 2020

Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer

International Journal of Molecular Sciences
Sangiliyandi GurunathanJin-Hoi Kim
September 12, 2020

NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma

Cellular and Molecular Life Sciences : CMLS
Alina NaveedArcha H Fox
September 13, 2020
Open Access

Brain metastasis from ovarian carcinoma: Analysis of eight cases from a single radiotherapy center

Taiwanese Journal of Obstetrics & Gynecology
Zumrut BahatErtugrul Cakir
September 15, 2020
Open Access

RNA Binding Protein LIN28B: a prime time player shaping neuroblastoma aggression and metastasis

Dongdong Chen, Robert W Schnepp

Sign up to follow this feed and discover related papers.

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (acc) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.


Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Amyloid

The relationship between astrocytes and amyloid has been suggested in some neurological diseases such as Alzheimer’s disease. Neuronal damage stimulates the activation of reactive astrocytes, which may the source of amyloid that forms in Alzheimer’s. Here is the latest research on astrocytes and amyloid.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes and Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.


Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research.

Autism: Motor Learning

A common feature of autism spectrum disorder (ASD) is the impairment of motor control and learning, consistent with perturbation in cerebellar function. Find the latest research on ASD and motor learning here.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

© 2020 Meta ULC. All rights reserved